Masimo Corporation
Clinical trials sponsored by Masimo Corporation, explained in plain language.
-
Smart monitor aims to cut unnecessary blood transfusions in surgery
Disease control TerminatedThis study tested a noninvasive device that measures hemoglobin and blood flow during surgery to help doctors decide when to give blood transfusions. It included 43 adults having major surgeries with expected blood loss. The study was terminated early, so results are limited.
Sponsor: Masimo Corporation • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
Pain relief device study for hip surgery halted early
Symptom relief TerminatedThis study looked at whether a device called the Bridge system could help manage pain after hip replacement surgery. Only 5 people took part before the study was stopped early. Because of the small number of participants, the results are not reliable enough to draw clear conclusi…
Sponsor: Masimo Corporation • Aim: Symptom relief
Last updated May 15, 2026 12:07 UTC
-
Can a simple device replace drugs for opioid withdrawal?
Symptom relief TerminatedThis study tested a device called Bridge to see if it could reduce opioid withdrawal symptoms. Researchers compared the real device to a fake one in 13 adults with opioid use disorder. The goal was to find a non-drug way to help people feel better during withdrawal.
Phase: NA • Sponsor: Masimo Corporation • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC
-
Surgery fluid predictor falls short: study halted
Knowledge-focused TerminatedThis study aimed to see if a new measurement called RPVi could help doctors predict when surgery patients need more fluids. It compared RPVi to standard methods like stroke volume variation. The study was stopped early and included 63 adults having elective surgery under general …
Sponsor: Masimo Corporation • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC